SI-BONE, Inc. (SIBN) stock
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3048% above fair value
$23.73−0.02 (-0.08%)
Close on Nov 20, 2026Market cap $1.06BP/E –Yield 0.00%
Si-Bone free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Si-Bone's free cash flow for the twelve months ending Jun 30, 2026 was -$4.39M. For fiscal 2025 it was -$9.09M. The highest annual figure on record is -$9.09M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.09M | – |
| FY2024 | Dec 31, 2024 | -$22.92M | – |
| FY2023 | Dec 31, 2023 | -$26.51M | – |
| FY2022 | Dec 31, 2022 | -$51.16M | – |
| FY2021 | Dec 31, 2021 | -$45.92M | – |
| FY2020 | Dec 31, 2020 | -$33.22M | – |
| FY2019 | Dec 31, 2019 | -$34.07M | – |
| FY2018 | Dec 31, 2018 | -$15.46M | – |
| FY2017 | Dec 31, 2017 | -$18.01M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$768.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.44M | – |
| Q4 FY2025 | Dec 31, 2025 | $440.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$620.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.93M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.09M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.73M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.45M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.65M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.39M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.30M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.33M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.44M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$16.84M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.79M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.49M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.73M | – |
| Q2 FY2021 | Jun 30, 2021 | -$10.37M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.34M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.70M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.03M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.25M | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.24M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.84M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.87M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.88M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.49M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.48M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.59M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.76M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.63M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.14M | – |
See a number that looks wrong?